Improving Aspirin Use in Diabetes: A Cluster Randomized Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00262977|
Recruitment Status : Completed
First Posted : December 7, 2005
Last Update Posted : July 22, 2010
|Condition or disease||Intervention/treatment||Phase|
|Diabetes Mellitus||Behavioral: Electronic prompt plus patient-directed intervention Behavioral: Electronic prompt to clinician to prescribe aspirin||Not Applicable|
Many patients with diabetes do not use aspirin to prevent cardiovascular events. Quality improvement initiatives involving both patients and physicians may be more effective than physician-directed approaches alone.
In a large urban primary care internal medicine practice, this study seeks to test if a patient-directed intervention is more effective than computerized clinician reminders alone for improving the appropriate use of aspirin in adults with diabetes.
The study design is a cluster-randomized trial by physician. The frequency of self-reported regular aspirin use will be compared between patients cared for by physicians in the computerized reminder alone group and the computerized reminder plus physician-supervised, nurse practitioner intervention group.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||300 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Improving Appropriate Aspirin Use Among Adults With Diabetes in a Primary Care Setting: Using an Electronic Medical Record to Target a Physician-supervised Nurse Practitioner Intervention|
|Study Start Date :||September 2004|
|Study Completion Date :||May 2005|
- Patient reported aspirin use daily or every other day.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00262977
|United States, Illinois|
|Northwestern University, Division of General Internal Medicine|
|Chicago, Illinois, United States, 60611|
|Principal Investigator:||Stephen D Persell, MD, MPH||Northwestern University|